Supply Chain

Health plans have long supplied their members with provider directories to assist in finding in-network physicians who are accepting new patients.

An advance copy of her remarks suggests Mylan CEO Heather Bresch plans to defend the price hike for the company's EpiPen before Congress Wednesday. However, Ms. Bresch will acknowledge that the drugmaker could have anticipated consumer distress over the significantly…

The Food and Drug Administration reported a shortage of Bristol-Myers Squibb's cancer drug Etopophos as of Sept. 16.

Ohio police departments are using up their supplies of the anti-overdose drug naloxone at a faster rate than normal to keep up with the state's high numbers of drug overdoses, reports KWQC.

Sarepta Therapeutics' newly approved Duchenne muscular dystrophy drugeteplirsen will cost about $300,000 a year, depending on patient weight, according to STAT.

The Food and Drug Administration recently approved KVK Tech's drug Lomaira.

Thirteen top drug companies joined efforts to fight antimicrobial resistance by vowing to reduce pollution emitted from antibiotic factories, according to a statement released on Tuesday.

Emma Walmsley will replace Andrew Witty as CEO of Britain-based GlaxoSmithKline when he retires on March 31, making her the first women to manage a leading global drug company, according to Reuters.

West Virginia Attorney General Patrick Morrisey (R) launched an investigation on Mylan over potential antitrust violations and state Medicaid fraud, reported USA Today.

Blackstone, a private equity company based in New York City, will purchase Irvine, Calif.-based LBA Realty's portfolio of logistics centers for $1.5 billion, according to The Wall Street Journal.